Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02418832
Other study ID # 0238-13-HMO
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 28, 2018
Est. completion date December 31, 2030

Study information

Verified date February 2024
Source Hadassah Medical Organization
Contact Benjamin E. Reubinoff, MD PhD
Phone 972-2-677-7485
Email benjaminr@ekmd.huji.ac.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Needle aspiration of the epididymis causes rupture and irreversible damage to the duct. Recurring punctures and needle aspirations of fluid and tissue during Testicular Fine Needle Aspiration (TEFNA) procedure cause irreparable injury and loss of part of the testis' tubules. The hypothesis of this research is that production of sperm from the testis will be improved due to ultrasonically guided Rete Testis needle aspiration. In cases of Obstructive Azoospermia, the Rete Testis is expected to contain a large number of sperm cells. In cases of Non-Obstructive Azoospermia, the investigators can expect to produce sperm cells from aspiration of the Rete Testis, which drains all of the testis' tubules. Furthermore, catheterization of the Rete Testis will allow for the drainage of all testes tubules and for the production of sperm cells created locally in some of the tubules or in parts of them. The potential advantage of needle aspiration from the Rete Testis is that the procedure will allow for the aspiration from all the testes tubules, as opposed to the standard method of sperm cells production from the testis which samples only some of the tubules. Therefore, it is expected that the procedure suggested in this research will be more efficient than the standard procedures currently in practice. An additional advantage to this procedure is that puncture and aspiration of the tubule network is not expected to block the drainage from the testis, as is the case in aspiration of the epididymis, and it is also not expected to damage the tubules, as is the case in TEFNA and in TESE.


Description:

Potential subjects will be Azoospermic men who turn to the IVF unit at Hadassah Ein Kerem and are candidates for a TEFNA treatment. Only after the men will receive an explanation of the TEFNA procedure and sign a consent form for TEFNA will they be invited to join the study. After an explanation, the men will sign a consent form (attached) for participation in the study. The TEFNA procedure in each testis will begin with an ultrasonically guided Rete Testis needle aspiration and washing of the testes tubules. A PP Spinal Needle, of 20-27 Gage and 90mm length, will be used for the ultrasonically guided puncture of the testis and catheterization of the Rete Testis network. After the catheterization, there will be an aspiration, followed by the washing of the testis tubule network in saline used for IV, in a volume of up to 1mL (5), using a 1mL syringe. In men with Obstructive Azoospermia, in case the samples aspirated from the Rete Testis will contain many motile sperm cells (more than hundreds), there will be no need for a TEFNA procedure. In cases where an initial sample of the Rete Testis aspiration will not show many motile sperm cells, the TEFNA procedure will continue on as planned. The samples from the Rete Testis aspiration will be separately checked for sperm cells from the sample and tissue produced from the TEFNA procedure. The sperm cells produced from the Rete Testis will be used for cryopreservation or fertilization of the ovum of the patient's partner, as is customary in sperm cells attained through the TEFNA procedure. Should sperm cells be produced both from the Rete Testis and from the epididymis or testes, the partner's ovum will be fertilized by the highest quality sperm cells of both sources. Clinical follow-up on patients will be conducted as customary after testis aspiration. The patients will be invited six months after the procedure for an ultrasonic check-up of the testes and the Rete Testis.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 31, 2030
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender Male
Age group 16 Years to 80 Years
Eligibility Inclusion Criteria: - Men with Obstructive/Non-Obstructive Azoospermia who turned to sperm cell aspiration for IVF and were found suitable for TEFNA and signed consent form. Exclusion Criteria: - healthy, non-azoospermic men - men who are unsuitable for the TEFNA procedure - men who don't sign the Informed Consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Sperm cell aspiration and TEFNA
Testicular Fine Needle Aspiration (TEFNA)

Locations

Country Name City State
Israel Hadassah University Medical Center, Ein Kerem Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

References & Publications (5)

Friedler S, Raziel A, Strassburger D, Soffer Y, Komarovsky D, Ron-El R. Testicular sperm retrieval by percutaneous fine needle sperm aspiration compared with testicular sperm extraction by open biopsy in men with non-obstructive azoospermia. Hum Reprod. 1997 Jul;12(7):1488-93. doi: 10.1093/humrep/12.7.1488. — View Citation

Hermann BP, Sukhwani M, Winkler F, Pascarella JN, Peters KA, Sheng Y, Valli H, Rodriguez M, Ezzelarab M, Dargo G, Peterson K, Masterson K, Ramsey C, Ward T, Lienesch M, Volk A, Cooper DK, Thomson AW, Kiss JE, Penedo MC, Schatten GP, Mitalipov S, Orwig KE. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell. 2012 Nov 2;11(5):715-26. doi: 10.1016/j.stem.2012.07.017. — View Citation

Lewin A, Reubinoff B, Porat-Katz A, Weiss D, Eisenberg V, Arbel R, Bar-el H, Safran A. Testicular fine needle aspiration: the alternative method for sperm retrieval in non-obstructive azoospermia. Hum Reprod. 1999 Jul;14(7):1785-90. doi: 10.1093/humrep/14.7.1785. — View Citation

Schlatt S, Rosiepen G, Weinbauer GF, Rolf C, Brook PF, Nieschlag E. Germ cell transfer into rat, bovine, monkey and human testes. Hum Reprod. 1999 Jan;14(1):144-50. doi: 10.1093/humrep/14.1.144. — View Citation

Schoysman R, Van Roosendaal E, Bollen N, Vandervorst M, Vanderzwalmen P, Standaert V, Berting G, Debauche C, Lefere C. Modern sperm retrieval techniques and their usefulness in oocyte fertilization. BJU Int. 2001 Jul;88(2):141-6. doi: 10.1046/j.1464-410x.2001.02301.x. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Ultrasound Guidance of Sperm Aspiration to Improve Efficiency of TEFNA The efficiency will be assessed by the percentage of participants in which at least one sperm cell will be successfully retrieved from ultrasound-guided Rete-Testis aspiration. The efficiency will be calculated separately for participants with Obstructive- and non-Obstructive Azoospermia. 5 years
See also
  Status Clinical Trial Phase
Completed NCT04675164 - Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men N/A
Not yet recruiting NCT02617173 - The Effect of Low Electrical Current on Testicular Spermatocyte Count N/A
Completed NCT01375062 - Obtaining Undifferentiated Cells From Testis Biopsy N/A
Active, not recruiting NCT05134428 - Safety Evaluation of the ADAM System N/A
Active, not recruiting NCT05866484 - Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
Enrolling by invitation NCT03762967 - Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility Phase 2
Completed NCT00484081 - Microdissection Testicular Sperm Extraction (MicroTESE) and IVF-ICSI Outcome in Non-Obstructive Azoospermia (NOA) N/A
Recruiting NCT02041910 - Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia Phase 1/Phase 2
Recruiting NCT02008799 - Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia N/A
Completed NCT01509482 - Insulin Resistance in Idiopathic Oligospermia and Azoospermia N/A
Completed NCT02339272 - Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility N/A
Completed NCT00548977 - Genetic Studies Spermatogenic Failure N/A
Recruiting NCT05479474 - Platelet Rich Plasma Testis Treatment for Infertile Men N/A
Not yet recruiting NCT02275169 - FSH Treatment for Non-obstructive Azoospermic Patients Phase 3
Recruiting NCT00282477 - Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls Phase 2
Recruiting NCT05628987 - The Association of Gut Microbiota and Spermatogenic Dysfunction
Recruiting NCT02544191 - GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia Phase 2
Enrolling by invitation NCT02307994 - Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH Phase 4
Completed NCT02414295 - Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection N/A
Terminated NCT02773498 - Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track N/A